# BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial

> **NCT04146012** · PHASE3 · TERMINATED · sponsor: **Artegraft, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Renal Insufficiency,Chronic

## Interventions

- **DEVICE:** Artegraft® Collagen Vascular Graft™ (Artegraft)

## Key facts

- **NCT ID:** NCT04146012
- **Lead sponsor:** Artegraft, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-03
- **Primary completion:** 2020-06-16
- **Final completion:** 2020-06-16
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Company was sold and clinical trial was suspended then teminated
- **Last updated:** 2023-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04146012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04146012, "BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04146012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*